PRKCE and fatty liver disease: In the liver, increased DAG content was associated with the activation of PKCε isoform both in experimental models of hepatic insulin resistance [40,41] and in humans with hepatic steatosis and insulin resistance [41], leading to impaired proximal insulin signaling.